Efficacy and Safety of tacalcitol ointment(20mcg/g) in Psoriasis Vulgaris - Double blind inter-group study compared with tacalcitol ointment(2mcg/g)(Study to obtain IDL) -

Trial Profile

Efficacy and Safety of tacalcitol ointment(20mcg/g) in Psoriasis Vulgaris - Double blind inter-group study compared with tacalcitol ointment(2mcg/g)(Study to obtain IDL) -

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Tacalcitol (Primary)
  • Indications Plaque psoriasis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Teijin Pharma
  • Most Recent Events

    • 27 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top